The Guggenheim CEO and LA Dodgers owner committed $100 million to start LA Rises, which he will lead with Magic Johnson and ...
Immunome, Inc. ("Immunome") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class ...
Immunome, Inc. ("Immunome") , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public ...
Fluence Energy (NASDAQ:FLNC – Get Free Report) had its target price lowered by equities researchers at Bank of America from $25.00 to $20.00 in a report released on Tuesday,Benzinga reports. The firm ...
BOTHELL, Wash. - Immunome, Inc. (NASDAQ:IMNM), a biotechnology firm engaged in the development of targeted cancer therapies, revealed plans for a public offering of $125 million in common stock. The ...
Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, ...